# Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease

> **NCT02778464** · — · COMPLETED · sponsor: **The Royal Wolverhampton Hospitals NHS Trust** · enrollment: 63 (actual)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Crohn's Disease (CD)
- Ulcerative Colitis (UC)
- Pregnancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02778464
- **Lead sponsor:** The Royal Wolverhampton Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-08
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778464, "Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02778464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*